Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in Bulgarian Hospitals
- 1 June 2008
- journal article
- research article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 14 (2), 119-128
- https://doi.org/10.1089/mdr.2008.0814
Abstract
The aim of the study was to describe the emergence, the spread, and the prevalence of extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae in Bulgaria. Over eight years (1996–2003), 442 ESBL-screen-positive isolates were collected in nine medical institutions in four Bulgarian towns. Class A ESBLs of the SHV, TEM, and CTX-M groups were identified in seven species. SHV-type enzymes persisted during the whole study period, TEM-ESBLs appeared first in 1999, and CTX-M–types appeared first in 2001. The rate of CTX-M enzyme producers increased rapidly between 2001 and 2003, while the rate of SHV producers decreased. Six different ESBL-types were identified, namely, SHV-2, −5, and −12, CTX-M-3 and −15, and a new TEM-3–like variant (TEM-139). The most widespread enzymes were SHV-12, CTX-M-15, and CTX-M-3 found in seven centers. TEM-139 was identified mainly in one center. A trend for strains harboring more than one ESBL gene, for example, CTX-M + SHV, was observed since 2002. Plasmid fingerprinting and random amplified polymorphic DNA analysis typing revealed wide dissemination of identical plasmids among different bacterial species and hospitals, as well as clonal spread of ESBL producers. Our data contribute to clarify the dynamics in the prevalence of ESBLs in Bulgaria and demonstrate the importance of molecular procedures for their analysis.Keywords
This publication has 33 references indexed in Scilit:
- Epidemiology of SHV-type β-lactamase-producing Klebsiella spp. from outbreaks in five geographically distant Hungarian neonatal intensive care units: widespread dissemination of epidemic R-plasmidsInternational Journal of Antimicrobial Agents, 2007
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Molecular Characterization and Occurrence of Extended-Spectrum β-Lactamase Resistance Genes among Salmonella enterica Serovar Corvallis from Thailand, Bulgaria, and DenmarkMicrobial Drug Resistance, 2006
- Epidemic and Endemic Spread ofKlebsiella pneumoniaeProducing SHV-5 Beta-Lactamase in Dubrava University Hospital, Zagreb, CroatiaJournal of Chemotherapy, 2005
- Complete Nucleotide Sequence of a 92-Kilobase Plasmid Harboring the CTX-M-15 Extended-Spectrum Beta-Lactamase Involved in an Outbreak in Long-Term-Care Facilities in Toronto, CanadaAntimicrobial Agents and Chemotherapy, 2004
- Molecular Characterization of β-lactam Resistance ofSalmonellaIsolates from Pediatric Patients in RomaniaJournal of Chemotherapy, 2004
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpCJournal of Antimicrobial Chemotherapy, 1999
- A Novel Type of AmpC β-Lactamase, ACC-1, Produced by a Klebsiella pneumoniae Strain Causing Nosocomial PneumoniaAntimicrobial Agents and Chemotherapy, 1999